Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas
eLife · 2024
DOI: 10.7554/elife.92774 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Anne Fajac und 14 weiteren Autor:innen. Beteiligte Einrichtung: Genetics of Tumor Suppression, Institut Curie, Paris, France. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Alternative Splicing, Protein Isoforms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation de France, Ligue Contre le Cancer, European Research Council.
Abstract (Originalsprache)
The Trp53 gene encodes several isoforms of elusive biological significance. Here, we show that mice lacking the Trp53 alternatively spliced (AS) exon, thereby expressing the canonical p53 protein but not isoforms with the AS C-terminus, have unexpectedly lost a male-specific protection against Myc-induced B-cell lymphomas. Lymphomagenesis was delayed in Trp53 +/+ Eμ-Myc males compared to Trp53 ΔAS/ΔAS Eμ-Myc males, but also compared to Trp53 +/+ Eμ-Myc and Trp53 ΔAS/ΔAS Eμ-Myc females. Pre-tumoral splenic cells from Trp53 +/+ Eμ-Myc males exhibited a higher expression of Ackr4, encoding an atypical chemokine receptor with tumor suppressive effects. We identified Ackr4 as a p53 target gene whose p53-mediated transactivation is inhibited by estrogens, and as a male-specific factor of good prognosis relevant for murine Eμ-Myc -induced and human Burkitt lymphomas. Furthermore, the knockout of ACKR4 increased the chemokine-guided migration of Burkitt lymphoma cells. These data demonstrate the functional relevance of alternatively spliced p53 isoforms and reveal sex disparities in Myc-driven lymphomagenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics of Tumor Suppression, Institut Curie, Paris, France.
- CNRS UMR3244, Paris, France.
- Sorbonne University, Paris, France.
- PSL Research University, Paris, France.
- Non Coding RNA, Epigenetic and Genome Fluidity, Institut Curie, Paris, France.
- School of Medicine, Ninewells Hospital, University of Dundee, Dundee, United Kingdom.
ORCID-Profile: Vincent Lejour, Antonin Morillon, Jean-Christophe Bourdon, Boris Bardot, Franck Toledo
Förderung
- Fondation de France
- Ligue Contre le Cancer
- European Research Council
- Fondation ARC pour la Recherche sur le Cancer
Zitieren
APA
Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Rakotopare, J., Vaysse-Zinkhöfer, W., Eldawra, E., Pinskaya, M., Morillon, A., Bourdon, J. C., Bardot, B., & Toledo, F. (2024). Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas. eLife. https://doi.org/10.7554/elife.92774
Vancouver
Fajac A, Simeonova I, Leemput J, Gabriel M, Morin A, Lejour V, et al. Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas. eLife. 2024. doi:10.7554/elife.92774
BibTeX
@article{Fajac2024,
author = {Fajac, Anne and Simeonova, Iva and Leemput, Julia and Gabriel, Marc and Morin, Aurélie and Lejour, Vincent and Hamon, Annaïg and Rakotopare, Jeanne and Vaysse-Zinkhöfer, Wilhelm and Eldawra, Eliana and Pinskaya, Marina and Morillon, Antonin and Bourdon, Jean-Christophe and Bardot, Boris and Toledo, Franck},
title = {Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.92774}
}
EUVIMED